Can the model of checkpoint inhibitor-induced adverse events based on B6/lpr mice be used as a mouse model of immunotherapy-induced pancreatitis?

Dear Dr. Kieran Adam and Dr. Adam Mor,

In your article “A novel mouse model for checkpoint inhibitor-induced adverse events”, the model constructed based on B6/lpr mice was checkpoint inhibitor-induced pancreatitis, but in Figure 2F, immune infiltration of the pancreas led to Read more Read less